Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

Delayed Quote. Delayed  - 10/20 05:31:27 pm
75.2 CHF   +0.40%
04:21p NOVARTIS : The American Heart Association and Novartis Shine a Light..
04:15p Positive Phase III Clinical Trial Results for Ribociclib (LEE011)..
04:07p CERULEAN PHARMA : CERU) Files An 8-K
News SummaryMost relevantAll newsSector news 
Latest news on NOVARTIS AG
09/16 Novartis Raises USD561.78 Million in Public Offering of International Bonds D..
09/16 MEREO BIOPHARMA : Progresses Drug Candidates In Maiden Interim Period
09/16 NOVARTIS : New Novartis data presented at ECTRIMS show benefit of Gilenya® on pa..
09/15 NOVARTIS : presents new positive data at EHMTIC showing AMG 334 significantly re..
09/15 NOVARTIS : Patent Issued for Use of an Adrenal Hormone-Modifying Agent (USPTO 94..
09/15 NOVARTIS : Foundation Showcases Progress In Leprosy Elimination Programs
09/15 NOVARTIS : Foundation showcases progress in leprosy elimination programs at 19th..
09/14 BIOGAIA : probiotics to be launched in Kenya, Nigeria and Ghana
09/13 NOVARTIS : Discoveries hit the back of the net with Novartis
09/12 Sanofi, Google parent form $500 million diabetes joint venture
09/12 NOVARTIS : New Novartis point of care Niji System may provide earlier diagnosis ..
09/11 NOVARTIS : Rochester doctor looking to begin his own trial of the treatment
09/11 NOVARTIS : Dementia treatment Cancer drug may help Parkinson’s and dementi..
09/09 NOVARTIS : Alcon launches the NGENUITY 3D Visualization System designed to furth..
09/09 NOVARTIS : Alcon Research Assigned Patent
09/09 NOVARTIS : New Novartis point of care Niji(TM) System may provide earlier diagno..
09/08 NOVARTIS : Alcon launches the NGENUITY® 3D Visualization System designed to furt..
09/07 Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corp..
09/07 NOVARTIS : Fight against Cancer
09/07 Drugmaker Vectura raises revenue outlook on strong trading
09/07 Sun pharma inks pact for distribution
09/07 Mitsubishi tanabe to distribute sun pharma's brands
09/06 Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corp..
09/03 NOVARTIS' : Ultibro® Breezhaler® consistently more effective than Seretide®* in ..
09/03 NOVARTIS : ' Ultibro® Breezhaler® consistently more effective than Seretide®* in..
09/02 MTOR Inhibitors Market 2016 - LC Laboratories, Biotool, Exelixis, Novartis, E..
09/02 NOVARTIS : Columbus Ledger-Enquirer, Ga., Alva James-Johnson column
09/01 NOVARTIS : Patent Application Titled "Cancer Treatment Method" Published Online ..
09/01 NOVARTIS : Pioneering Alzheimer's prevention study starts enrolling high-risk ol..
09/01 NOVARTIS INDIA : Announces Results for the Quarter and Nine Months ended 31 Dece..
09/01 NOVARTIS : FDA approves Novartis' biosimilar to treat multiple inflammatory dise..
09/01 NOVARTIS : Alcon LenSx Assigned Patent
08/31 NOVARTIS : FDA approves Sandoz Erelzi to treat multiple inflammatory diseases
08/31 VECTURA : Notes Positive Study Data From Novartis For AirFluSal Forspiro
08/31 NOVARTIS : AirFluSal® Forspiro® showed superiority at 12 months over Seretide® D..
08/30 AMGEN : Novartis wins US OK for biosimilar version of Amgen's Enbrel
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30 NOVARTIS : FDA approves Sandoz Erelzi(TM) to treat multiple inflammatory disease..
08/30 CONTRACT AWARD - J-- GOVERNMWNT OWNE : Pmi constellation: 9/1/16-8/31/17
08/30 NOVARTIS : $12,482 Federal Contract Awarded to Alcon Laboratories
08/30 NOVARTIS AG (ADR) (NYSE : NVS) Says A Picture Is Worth A Thousand Words
08/29 GLAXOSMITHKLINE : Ahmed - GSK Has Full Confidence in the Nigerian Economy
08/29 AHMED : GSK Has Full Confidence in the Nigerian Economy
08/29 NOVARTIS : convenes experts to discuss new technologies in healthcare at Interna..
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 LEPLEY REELS IN TOP HONOURS FOR NOVA : Tony Burman catches up with the angling a..
08/26 NOVARTIS AG (NYSE : NVS) Announces Positive Phase III Results For MS Drug
08/26 NOVARTIS : Alcon Research Assigned Patent
08/25 NOVARTIS' : phase III MS study successfully meets endpoints
08/25 NOVARTIS : announces positive phase III results showing efficacy of BAF312 in pa..
08/24 NOVARTIS AG (NYSE : NVS) Licenses LGT209 To Cyon Therapeutics, Inc., Teams Up Wi..
08/24 NOVARTIS : Today's Cartoon (August 24 2016)
08/23 NOVARTIS : Kenya Red Cross Society and Novartis Join Forces
08/22DJEli Lilly, AstraZeneca Progress With Alzheimer's Drug
08/19 NOVARTIS : Alcon Research Assigned Patent
08/18 NOVARTIS : New drugs hope to fight neglected tropical diseases
08/18 JACOBS ENGINEERING : Awarded Contract for Novartis Biotechnology Center Expansio..
08/18 NOVARTIS : Patent Issued for Combination Therapy (USPTO 9408847)
08/18 NOVARTIS : NICE says Novartis' and Janssen's cancer drugs are not cost effective
08/17 NOVARTIS : Turkey's investigation into drugmaker Novartis 'ongoing' - official
08/17 CSL : Full Year Result 2016CSL Delivers Another Strong Performance
08/15DJStada Arzneimittel Braced for Investor Battle
08/15 NOVARTIS : Six leading scientists to receive prestigious Novartis Prizes for Imm..
08/15 NOVARTIS : Six leading scientists to receive prestigious Novartis Prizes for Imm..
08/13 NOVARTIS : Korea executives charged for bribing doctors
08/13 NOVARTIS : Korea executives charged with bribing doctors
08/13 DALTON STARS AT SALTFLEETBY AS RIVAL : Tony Burman catches up with the angling a..
08/12 JACOBS ENGINEERING : Awarded Contract for Novartis Biotechnology Center Expansio..
08/12 NOVARTIS : Korea mired in `rebate' scandal
08/12 NOVARTIS : faces potential South Korea sales ban
08/11 NOVARTIS : execs in Korea are indicted for bribing doctors
08/11 NOVARTIS : Patent Issued for Two Dimensional Forward Scanning Probe (USPTO 94025..
Prev.1   2  3  4  5  6  7  8  9  10Next
Financials ($)
Sales 2016 48 957 M
EBIT 2016 11 832 M
Net income 2016 7 824 M
Debt 2016 14 563 M
Yield 2016 3,75%
P/E ratio 2016 22,33
P/E ratio 2017 20,41
EV / Sales 2016 4,36x
EV / Sales 2017 4,24x
Capitalization 198 899 M
More Financials
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 29
Average target price 89,1 $
Spread / Average Target 18%
Consensus details
EPS Revisions
More Estimates Revisions
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-13.42%198 899
JOHNSON & JOHNSON11.56%313 504
ROCHE HOLDING LTD.-15.48%204 044
PFIZER INC.0.99%197 740
MERCK & CO., INC.17.13%171 083
More Results